Successful treatment with nilotinib after bosutinib-induced pulmonary arterial hypertension recurrence following dasatinib in chronic myeloid leukemia in chronic phase
2022 · Leukemia Research Reports · 4 citations
https://doi.org/10.1016/j.lrr.2022.100312